NASP Applauds the Senate Finance Committee for Taking Additional Steps to Address Anticompetitive PBM Practices
|Urges the Advancement of Legislation To Support Specialty Pharmacies and Patient Pharmacy Choice|
The National Association of Specialty Pharmacy (NASP) thanks the Senate Finance Committee for its bipartisan efforts to address anticompetitive practices that ultimately harm beneficiary access to the specialty pharmacy of their choice. The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act that advanced out of the Committee today, seeks to build on the pharmacy protections included in the Modernizing and Ensuring PBM Accountability Act thatadvanced out of the committee in July. Today’s legislation includes efforts to strengthen and enforce the long-standing federal Any Willing Pharmacy law, an NASP advocacy priority.